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A growing body of data shows that bacteriophages can interact with different kinds of
immune cells. The objective of this study was to investigate whether T4 bacteriophage
and T4-generated Escherichia coli lysate affect functions of monocytes, the key
population of immune cells involved in antibacterial immunity. To that end, we evaluated
how T4 and E. coli lysate influence the expression of main costimulatory molecules
including CD40, CD80 and CD86, TLR2, TLR4 on monocytes, as well as the production
of IL-6 and IL-12 in cultures of peripheral blood mononuclear cells (PBMCs). Separate
experiments were performed on unactivated and LPS-activated PBMCs cultures. Both
studied preparations significantly increased the percentage of CD14+CD16−CD40+
and CD14+CD16−CD80+ monocytes in unactivated PBMCs cultures, as well as the
concentration of IL-6 and IL-12 in culture supernates. However, neither purified T4
nor E. coli lysate had any significant effect on monocytes in LPS-activated PBMCs
cultures. We conclude that LPS-activated monocytes are unresponsive to phages and
products of phage-induced lysis of bacteria. This study is highly relevant to phage
therapy because it suggests that in patients with infections caused by Gram-negative
bacteria the administration of phage preparations to patients and lysis of bacteria by
phages are not likely to overly stimulate monocytes.
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INTRODUCTION
Bacteriophages are increasingly considered as a means of treatment of bacterial infections,
including those caused by antibiotic-resistant bacteria (Mie˛dzybrodzki et al., 2012; Kutter et al.,
2015). However, during treatment, phages can interact not only with bacteria, but also with
different populations of immune cells including those involved in the induction of antibacterial
immune responses (Górski et al., 2012). An important kind of immune cells engaged in
antibacterial immunity are monocytes (Lauvau et al., 2015). These are cells of myeloid origin that
constitute 5–12% of leukocytes in the peripheral blood in humans. The life span of monocytes in
blood is up to 2 days. While unactivated monocytes undergo apoptosis, activation by different
factors associated with ongoing infection or inflammation results in apoptosis inhibition, and
monocytes migrate into inflamed tissues, phagocytose apoptotic cells, cellular debris, and different
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particles. In addition, monocytes can differentiate into
macrophages and inflammatory dendritic cells (iDCs; Swirski
et al., 2014). Along with DCs and macrophages, monocytes
comprise a heterogeneous population of mononuclear
phagocytes (MPS) involved in antigen processing and
presentation to initiate and regulate immune responses to
pathogens, vaccines, tumors, and tolerance to autoantigens.
Main functions of the MPS system include tissue maintenance
and healing, innate immunity and pathogen clearance, and the
induction of adaptive immune responses (Reynolds and Haniffa,
2015).
Monocytes are one of the key populations of immune cells
to combat bacterial infections. Apart from direct antibacterial
effects mediated by phagocytosis, reactive oxygen species, and
nitric oxide, monocytes are also involved in regulation of both
innate and adaptive immune responses during infections (Lauvau
et al., 2015). Given a central role of monocytes during bacterial
infections, we investigated whether bacteriophages could affect
functions of this population of cells. Because during ongoing
infection monocytes can be activated by different components
of bacterial cells including lipopolysaccharide (LPS; Salomao
et al., 2012), we also included to our study experiments to
investigate whether bacteriophages affect functions of LPS-
activated monocytes. Our study focused on CD14+CD16− classic
monocytes, the most abundant subpopulation of these cells
(Ziegler-Heitbrock, 2015).
The study was performed on T4 phage that for decades has
been the model phage in various studies and has been extensively
characterized at the genetic and molecular level (Leiman et al.,
2003). Moreover, T4 was used in previous studies of the effects
of phages on the immune system (Górski et al., 2012), as well
as in the first randomized placebo-controlled safety test of phage
therapy (Bruttin and Brüssow, 2005).
MATERIALS AND METHODS
Bacteriophage
T4 phage was obtained from American Type Culture Collection
(ATCC; USA) and was propagated on E. coli B from the
Collection of Microorganisms of the L. Hirszfeld Institute
of Immunology and Experimental Therapy (IIET), Wrocław,
Poland.
Purified preparation of T4 phage was prepared by Laboratory
of Bacteriophages, IIET, according to the protocol reported in
detail by Boratyn´ski et al. (2004). In brief, phage purification
involved sequential ultrafiltration of crude T4 phage-generated
E. coli B lysate through polysulfone membranes followed by
chromatography on sepharose 4B (Sigma–Aldrich, Poland) and
cellulofine sulfate (Millipore, USA). Stock preparations of T4
were suspended in phosphate-buffered saline (PBS; Biomed,
Poland). Phage titer was measured by two-layer method of
Adams (Adams, 1959).
The concentration of LPS in purified T4 phage preparation
was determined using QLC-1000 Endpoint Chromogenic LAL
test kit (Lonza, Switzerland) according to the manufacturer’s
instructions. The concentration of LPS in the preparation was
3 ng/ml. Therefore, in immunological experiments, LPS (Sigma–
Aldrich, Poland) diluted with PBS was used at a concentration
of 3 ng/ml as an additional control for purified T4 phage
preparation.
Bacterial Lysate
T4 phage-generated bacterial lysate was prepared by Laboratory
of Bacteriophages, IIET, according to the protocol reported by
Slopek et al. (1983) and Letkiewicz et al. (2009). In brief, T4
was incubated with E. coli B in LB medium (Sigma–Aldrich,
USA) at 37◦C until complete bacterial lysis (approx. 4–6 h). Next
the suspension was filtered through a 0.22-µm filter (Millipore,
USA). Stock preparation of the lysate was suspended in peptone
water (IIET, Poland). Phage titer in lysate was measured by
two-layer method of Adams (Adams, 1959).
In immunological experiments an additional control for T4-
generated E. coli lysate was peptone water.
Cell Cultures
All experiments were performed on cells isolated from healthy
blood donors. Informed, written consent was obtained from
all donors. The study protocol was approved by the ethics
committee of the Medical University of Warsaw. Peripheral
blood mononuclear cells (PBMCs) were isolated from blood
specimens by density-gradient centrifugation over Gradisol L
(Aqua Medica, Poland). PBMCs were cultured at a density of
1 × 106/ml in RPMI medium (Biomed, Poland) supplemented
with FCS (Sigma–Aldrich, USA), L-glutamine (Sigma–Aldrich,
USA), HEPES (Sigma–Aldrich, USA), and gentamicin (Krka,
Slovenia) in 24-well plates at 37◦C with 5% CO2 for 24 h. In
each experiment, two parallel cultures were set up. In one culture,
PBMCs were activated with LPS (Sigma–Aldrich; 10 µg/ml),
and in the other cells were treated with equal volume of PBS.
Simultaneously, in some cultures purified T4 phage (108 PFU/ml;
final concentration), E. coli lysate (containing T4 phage at the
final concentration of 108 PFU/ml), control LPS (3 ng/ml), or
peptone water was also added to wells. In control cultures equal
volume of PBS was added to wells. After 24 h of culture viability
of PBMCs was determined using trypan blue. The viability of cells
was consistently 95%. PBMCs were harvested for flow cytometry
analysis of surface markers, and culture supernates were frozen at
−20◦C for measurements of cytokines concentrations.
Evaluation of Expression of Monocytes
Surface Markers
Cells were incubated with the following monoclonal antibodies:
CD14-PerCP (BD Pharmingen, USA), CD16-FITC (BD
Pharmingen), CD80-FITC (BD Pharmingen), CD86-PE
(BD Pharmingen), CD40-PE (BD Pharmingen), TLR2-FITC
(eBioscience, USA), and TLR4-PE (eBioscience). In isotype
controls cells were stained with IgG1 conjugated with the
respective fluorochromes (BD Pharmingen, eBioscience). After
30 min of incubation at 4◦C, cells were washed twice in FACS
buffer (Becton Dickinson, USA). The expression of monocytes
surface markers was measured by flow cytometry (FACSCalibur,
Becton Dickinson) and analyzed by Cell Quest software (Becton
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Dickinson). The results were based on analysis of at least 100,000
cells and were shown as the percentage of positively labeled cells.
Moreover, the mean fluorescence intensity (MFI) values of gated
monocytes positive for individual markers were determined.
Determination of Cytokine Production
The concentrations of IL-6 and IL-12 (p70) were measured in
cell culture supernates by enzyme-linked immunoassay (ELISA)
using Human IL-6 and IL-12 p70 ELISA Ready-SET-Go kits
(eBioscience) according to the manufacturer’s instructions.
Statistics
Statistical analysis of the results was performed by Wilcoxon’s
matched pairs test. P < 0.05 was considered significant.
RESULTS
In order to investigate the effects of T4 bacteriophage and T4-
generated E. coli lysate on monocytes, we determined: (1) the
expression of main costimulatory molecules including CD40,
CD80, and CD86, (2) the expression of TLR2 and TLR4
molecules, and (3) the production of IL-6 and IL-12. In each
case, separate experiments were performed on unactivated and
LPS-activated PBMCs.
In the first set of experiments, we evaluated whether
T4 bacteriophage and T4-generated E. coli lysate affect the
expression of CD40, CD80, and CD86 in CD14+CD16−
monocytes. In unactivated PBMCs cultured with T4 phage,
the mean percentage of CD14+CD16−CD40+ monocytes was
45.47 ± 19.5, while in the control (unactivated PBMCs to
which equal volume of PBS was added) this percentage was
16.55 ± 7.61 (p = 0.016; Figure 1A). However, a comparable
increase in the mean percentage of CD14+CD16−CD40+ cells
was observed in unactivated PBMCs cultured with control
LPS (58.99 ± 25.39); the difference between the mean
percentage of CD14+CD16−CD40+ monocytes in cultures
to which T4 phage or control LPS was added was not
statistically significant. Similarly to T4 phage, T4-generated
E. coli lysate significantly increased the mean percentage of
CD14+CD16−CD40+ monocytes to 52.81 ± 17.02 (p = 0.008
compared with the control). On the other hand, we found
no significant differences between the MFI values of CD40
in CD14+CD16− monocytes from PBMCs cultures to which
PBS, T4 phage, control LPS, or E. coli lysate was added
(Table 1). In LPS-activated PBMCs cultures, the percentage of
CD14+CD16−CD40+ monocytes was comparable in all culture
variants (65.6 ± 14.17, 65.49 ± 17.1, 63.49 ± 15.87, and
59.37 ± 37 for variants to which PBS, T4 phage, control
LPS, or E. coli lysate was added, respectively). Furthermore,
in LPS-activated PBMCs cultures the MFI values of CD40 in
CD14+CD16− monocytes were also comparable in all culture
variants (Table 1).
Moreover, we found that T4 phage significantly increased
the mean percentage of CD14+CD16−CD80+ monocytes
in unactivated PBMCs cultures compared with the control
(77.55 ± 13.31 and 37.91 ± 14.06 for cells cultured in the
presence of T4 and control cells, respectively; p = 0.0006;
Figure 1B); however, a similar increase in the mean percentage
of CD14+CD16−CD80+ monocytes was observed in cultures
to which control LPS was added (80.61 ± 11.38). Like T4
phage, E. coli lysate significantly increased the mean percentage
of CD14+CD16−CD80+ monocytes (71.2 ± 14.75; p = 0.0019
compared with the control). In addition, we found that in
unactivated PBMCs cultures, T4, control LPS, and E. coli lysate
significantly increased the MFI values of CD80 in CD14+CD16−
monocytes compared with the control (p = 0.0063, p = 0.00238,
and p = 0.0379 for T4 phage, control LPS, and E. coli lysate,
respectively; Table 1).
In LPS-activated PBMCs, the mean percentage of
CD14+CD16−CD80+ monocytes was comparable in cultures to
which PBS, T4 phage, control LPS, or E. coli lysate was added
(95.61 ± 3.16, 96.41 ± 3.55, 87.26 ± 12.38, and 95.17 ± 3.13,
respectively; Figure 1B). Furthermore, in LPS-activated PBMCs,
we found no statistically significant differences between the MFI
values of CD80 in CD14+CD16− monocytes from individual
culture variants (Table 1).
We also found that neither T4 phage nor E. coli lysate
had any significant effect on the mean percentage value of
CD14+CD16−CD86+ monocytes in unactivated PBMCs; these
values were 90.8 ± 11.3, 83.3 ± 11.31, and 73.56 ± 13.25 in
cultures to which PBS, T4 phage, or lysate was added (Figure 1C).
The corresponding MFI values were also comparable in all
culture variants (Table 1). Likewise, in LPS-activated PBMCs, we
found no significant differences between the mean percentage of
CD14+CD16−CD86+ monocytes in individual culture variants
(73.56 ± 13.25, 90.87 ± 8.0, and 94.33 ± 6.87 in cultures to
which PBS, T4 phage, or E. coli lysate was added, respectively;
Figure 1C). In addition, we found that in LPS-activated PBMCs
neither of the studied preparations significantly affected the MFI
value of CD86 in CD14+CD16− monocytes (Table 1).
In the second set of experiments, we evaluated whether
T4 phage and E. coli lysate affect the expression of TLR2
and TLR4 on CD14+CD16− monocytes. Overall, neither of
the studied preparations significantly affected the expression of
TLR2 or TLR4. In unactivated PBMCs the mean percentage
of CD14+CD16−TLR2+ cells was comparable in all culture
variants (75.81 ± 15.87, 90.42 ± 6.8, and 83.54 ± 9.21
in cultures to which PBS, T4 phage, or lysate was added;
Figure 2). In LPS-activated PBMCs the corresponding values
were 83.21 ± 25.21, 88.69 ± 8.8, and 87.98 ± 12.71. The mean
percentage of CD14+CD16−TLR4+ cells in unactivated PBMCs
cultures was 51.53 ± 35.74, 47.73 ± 39.01, and 60.02 ± 34.02 in
control cultures and cultures to which T4 phage or lysate was
added (Figure 2). In LPS-activated PBMCs these values were
65.04± 38.4, 47.73± 39.01, and 60.02± 34.02.
Moreover, we evaluated whether the investigated preparations
stimulate the production of pro-inflammatory cytokines IL-6
and IL-12. We found that both T4 phage and E. coli lysate
significantly increased the concentration of IL-6 in supernates
of unactivated PBMCs cultures compared with the control (the
mean concentration of IL-6 3.47 ± 2.62, 111.58 ± 15.11, and
99.68 ± 5,32 pg/ml in control cultures and cultures to which T4
or lysate was added, respectively; p = 0.0294 for both T4 and
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FIGURE 1 | The effects of T4 phage and T4-generated Escherichia coli lysate on the expression of costimulatory molecules on monocytes. The
percentage values of CD40+ (A), CD80+ (B), and CD86+ (C) cells were determined by flow cytometry in CD14+CD16− monocytes from 24-h cultures of peripheral
blood mononuclear cells (PBMCs). The expression of each marker was determined separately on monocytes from cultures of unactivated (gray bars) and
LPS-activated (white bars) PBMCs. T4 phage or E. coli lysate was present in culture medium throughout the culture. Shown are the mean percentage
values ± standard deviation. Statistically significant differences (p < 0.05) are marked with ∗.
lysate; Figure 3). A comparable increase in IL-6 concentration
was observed in supernates of unactivated PBMCs cultures to
which control LPS was added (115.99 ± 10.86 pg/ml; p = 0.0294
compared with the control; Figure 3). In LPS-activated PBMCs
cultures the mean IL-6 concentration exceeded 100 pg/ml and
was comparable in all culture variants (Figure 3).
Similar results were obtained for IL-12. Both T4 and E. coli
lysate significantly increased the concentration of this cytokine
in supernates of unactivated PBMCs cultures compared with
the control (mean IL-12 concentrations 0.0, 8.22 ± 4.25,
5.42 ± 2.25 pg/ml in control cultures and cultures to which
T4 or lysate was added, respectively; p = 0.211 for both T4
and lysate; Figure 3). IL-12 concentration was also significantly
increased in supernates of unactivated PBMCs cultured with
control LPS (19.92 ± 8.75 pg/ml; p = 0.0211 compared with
the control; Figure 3). In supernates of LPS-activated PBMCs
cultures the concentration of IL-12 was above 10 pg/ml and,
we found no significant differences between individual culture
variants (Figure 3).
DISCUSSION
The objective of this study was to evaluate whether
bacteriophages can affect functions of monocytes, a key
population of immune cells involved in antibacterial immunity
(Lauvau et al., 2015). We focused on CD14+CD16− classic
monocytes, the most abundant subpopulation of monocytes
(Ziegler-Heitbrock, 2015). All experiments were performed
on T4 phage, a model dsDNA bacterial virus that has been
extensively characterized at the genetic and molecular level
(Leiman et al., 2003). Apart from purified preparation of T4, we
used T4-generated E. coli lysate. In vitro experiments involving
use of lysate were intended to mimic the effects of lysis of
bacteria in a patient treated with a phage preparation. Thus,
by using lysate, we investigated whether monocytes functions
can be affected by products of phage-induced lysis of bacterial
cells. Moreover, lysates are used in the treatment of bacterial
infections at some centers of phage therapy (Mie˛dzybrodzki
et al., 2012).
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TABLE 1 | The mean fluorescence intensity (MFI) of costimulatory molecules and TLRs on monocytes cultured with T4 phage and T4-generated
Escherichia coli lysate.
CD40 CD80 CD86 TLR2 TLR4
Monocytes Unactivated 28.75
(± 8.44)
59.05
(± 11.82)
374.04
(± 318.90)
64.72
(± 23.77)
62.61
(± 22.95)
Activated
LPS 10 ug/ml
37.62
(± 21.42)
150.56
(± 118.72)
153.66
(± 66.54)
125.37
(± 66.10)
63.11
(± 26.05)
Peptone water + Monocytes unactivated 29.20
(± 5.46)
59.53
(± 19.55)
399.41
(± 315.84)
71.97
(± 24.78)
47.43
(± 15.37)
Monocytes activated
LPS 10 ug/ml
29.65
(± 12.38)
96.21
(± 49.61)
148.48
(± 81.07)
104.11
(± 47.23)
65.04
(± 27.26)
Control LPS + Monocytes unactivated 44.55
(± 16.76)
∗131.06
(± 87.81)
150.05
(± 66.72)
94.09
(± 60.03)
50.01
(± 22.77)
Monocytes activated
LPS 10 ug/ml
38.94
(± 20.31)
150.34
(± 105.49)
160.18
(± 81.20)
151.84
(± 69.18)
55.67
(± 19.85)
T4 phage + Monocytes unactivated 34.49
(± 11.65)
∗134.02
(± 74.33)
275.61
(± 128.34)
103.92
(± 57.42)
49.42
(± 15.61)
Monocytes activated
LPS 10 ug/ml
41.04
(± 26.74)
147.55
(± 103.47)
164.68
(± 76.70)
111.88
(± 44.85)
87.26
(± 86.90)
Bacterial lysate + Monocytes unactivated 36.94
(± 11.90)
∗114.75
(± 61.45)
194.53
(± 90.40)
116.61
(± 58.27)
87.44
(± 41.24)
Monocytes activated
LPS 10 ug/ml
34.46
(± 18.15)
107.77
(± 63.2)
181.53
(± 70.96)
130.88
(± 62.69)
52.43
(± 15.36)
The MFI of costimulatory molecules (CD40, CD80, CD86), TLR2, and TLR4 was determined by flow cytometry in CD14+CD16− monocytes from 24-h cultures of
peripheral blood mononuclear cells (PBMCs). All experiments were performed on unactivated PBMCs (results in white boxes) and LPS-activated PBMCs (results in gray
boxes). T4 phage or E. coli lysate was present in culture medium throughout the culture. Shown are the MFI values± standard deviation. Statistically significant differences
(p < 0.05) are marked with ∗.
FIGURE 2 | T4 phage and T4-generated Escherichia coli lysate do not affect the expression TLR2 and TLR4 on CD14+CD16− monocytes. The
percentage values of TLR2+ (A) and TLR4+ (B) cells were determined by flow cytometry in CD14+CD16− monocytes from 24-h cultures of PBMCs. The expression
of both markers was determined separately on monocytes from cultures of unactivated (gray bars) and LPS-activated (white bars) PBMCs. T4 phage or E. coli lysate
was present in culture medium throughout the culture. Shown are the mean percentage values ± standard deviation.
All experiments were performed on both unactivated and
LPS-activated PBMCs. LPS is the principal component of
Gram-negative bacterial cells known to activate monocytes in
different infections including sepsis (Salomao et al., 2012).
Experimental variants involving LPS-activated monocytes were
included to evaluate whether bacteriophages can affect functions
of monocytes that are in a state corresponding to that found
in patients with ongoing bacterial infection. Recent microarray-
based gene expression studies confirmed that in patients with
bacterial infections, especially sepsis, PBMCs are activated, as
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FIGURE 3 | T4 phage and T4-generated Escherichia coli lysate have no effect on the production of pro-inflammatory cytokines by LPS-activated
PBMCs. Concentration of pro-inflammatory cytokines – IL-6 (Left) and IL-12 (Right) – was measured by ELISA in supernates from 24-h cultures of PBMCs.
Production of both cytokines was evaluated separately in cultures of unactivated (black bars) and LPS-activated (white bars) PBMCs. T4 phage or E. coli lysate was
present in culture medium throughout the culture. Shown are the mean concentrations ± standard deviation. Statistically significant differences (p < 0.05) are
marked with ∗.
reflected by up-regulation of many genes involved in antibacterial
immunity and inflammatory responses (Maslove and Wong,
2014; Severino et al., 2014).
We found that both purified T4 and E. coli lysate significantly
increased the percentage of CD14+CD16−CD40+ and
CD14+CD16−CD80+ monocytes in unactivated PBMCs
cultures without any significant effect on the percentage
of CD14+CD16−CD86+ monocytes. However, we also
observed a significant increase in the percentage of both
CD14+CD16−CD40+ and CD14+CD16−CD80+ monocytes
in unactivated PBMCs cultured with control LPS (used at
a concentration of 3 ng/ml that corresponds to that found
in T4 phage preparation). These findings suggest that the
increase in the percentage of CD14+CD16−CD40+ and
CD14+CD16−CD80+ monocytes observed in unactivated
PBMCs cultured with purified T4 preparation was caused by
residual LPS rather than bacteriophage virions themselves.
CD40, a member of the TNF receptor family, plays an
important role in both cellular and humoral immune responses.
Signaling through CD40 up-regulates the expression of a number
of molecules including MHC class II, CD80, CD86, adhesion
molecules and induces the production of cytokines such as IL-
1, IL-6, IL-10, and TNF-α (Wu et al., 2009). Thus, our results
suggest that in unactivated monocytes some products of phage-
induced lysis of bacterial cells, especially LPS, may promote
CD40-mediated humoral and cellular immune responses.
CD80 is a molecule whose expression on monocytes is
increased following stimulation by some factors including LPS.
CD80 can prolong or enhance costimulatory signals transmitted
from antigen-presenting cells (APCs) to CD4+ T cells thus
promoting the activation of these cells (Rutkowski et al., 2003).
Therefore, our data indicate that LPS, and possibly some other
components of E. coli cells released from bacteria during phage-
induced lysis can promote CD80-mediated costimulation of
CD4+ T cells.
Importantly, we also found that in LPS-activated PBMCs
cultures the percentage of CD40, CD80, and CD86 on
CD14+CD16− monocytes was unaffected by purified T4 and
E. coli lysate. These results suggest that in patients with infections
caused by Gram-negative bacteria the administration of phage
preparations, as well as lysis of bacteria by phage, is not
likely to affect CD40-, CD80-, and CD86-mediated functions of
monocytes.
We also showed that neither of the studied preparations
significantly affected the expression of TLR2 and TLR4 on
CD14+CD16− monocytes both in unactivated and LPS-activated
PBMCs cultures. TLRs are the key class of pattern-recognition
receptors involved in the induction of innate immune responses
to various pathogens (De Nardo, 2015). Thus our results suggest
that neither phage nor products of lysis of bacterial cells are likely
to affect TLR2- and TLR4-mediated immune responses.
Moreover, we showed that both T4 and E. coli lysate
significantly increased the concentration of IL-6 and IL-12 in
supernates of unactivated PBMCs cultures. While IL-6 and IL-
12 are generally classified as “proinflammatory,” in fact their
actual biological effects are highly context-dependent and both
cytokines may even exert anti-inflammatory activity (Chang
and Radbruch, 2007; Hunter and Jones, 2015). Our previous
observations indicate that lysates used for therapeutic purposes
do not induce any proinflammatory effects in patients. For
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example, lysates did not increase leukocytosis, sedimentation
rate, and the concentration of C-reactive protein (CRP) in
patients; furthermore, in individuals with the initial CRP
concentration above 10 mg/l, a significant reduction in the
concentration of this protein was shown between days 9 and 32 of
treatment (Mie˛dzybrodzki et al., 2012). In line with our previous
findings are the results of the present study that show that neither
T4 nor E. coli lysate significantly increased the production of IL-6
and IL-12 in LPS-activated PBMCs cultures.
An important question is whether our results obtained for
T4 phage and E. coli lysate can be extrapolated to other phages
and bacterial lysates. At the present state of research it is
hard to formulate general conclusions especially with respect
to phages because it is known that structure of tailed phages
is highly diversified and substantial differences in amino-acid
sequences of phage proteins, including surface capsid proteins
have been reported (Fokine and Rossmann, 2014). Therefore,
it is possible that some phages have proteins that can activate
some functions of monocytes. With respect to bacterial lysates,
we believe that some differences between the effects of Gram-
negative and Gram-positive bacteria might be expected due to
different structure and composition of their cell walls (Silhavy
et al., 2010). Thus, further studies should be conducted to
evaluate whether activated monocytes are also refractory to other
phages and phage-generated bacterial lysates.
CONCLUSION
While LPS, and possibly some other products of phage-induced
lysis of E. coli affect the phenotype of unactivated monocytes and
production of cytokines by unactivated PBMCs, LPS-activated
cells are unresponsive to both phage virions and products
of phage-induced lysis of bacterial cells. Our results are of
importance to phage therapy because they suggest that the
administration of phage preparations to patients with infections
caused by Gram-negative bacteria and subsequent lysis of
bacteria by phages are not likely to overly stimulate monocytes.
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